Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?

Neurology

Volumn 63, Issue 7, 2004, Pages 1276-1280

  Umehara, F ^a   Nagatomo, S ^a   Yoshishige, K ^a   Saito, M ^a   Furukawa, Y ^a   Usuku, K ^a   Osame, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL MYELOPATHY; CERVICAL SPINAL CORD INJURY; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; NERVE CONDUCTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SPASTIC PARAPLEGIA; SPINAL CORD ATROPHY; SPINAL CORD BIOPSY;

EID: 5344237418     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000140496.03342.BC     Document Type: Article

References (15)

1. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic type I and adult T cell leukemia-like cells. Ann Neurol 1987;21:117-122.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410.
3. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-123.
4. Umehara F, Osame M. Histological analysis of HAM/TSP pathogenesis. In: Sugamura K, Uchiyama T, Masao M, Kannagi M, eds. Two decades of adult T-cell leukemia and HTLV-I research. Tokyo: Japan Scientific Societies Press, 2003:141-148.
5. Vine AM, Witkover AD, Lloyd AL, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2002;186:932-939.
6. Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999;96:3848-3853.
7. Jeffery KJ, Siddiqui AA, Bunce M, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000;165:7278-7284.
8. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990:191-197.
9. Furukawa Y, Yamashita M, Usuku K, et al. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000;182:1343-1349.
10. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-593.
11. Tajima Y, Kishimoto R, Sudoh K, et al. Spinal magnetic resonance image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatment. J Neurol 2003;250:750-753.
12. Shakudo M, Inoue Y, Tukada T. HTLV-I-associated myelopathy: acute progression and atypical MR findings. AJNR Am J Neuroradiol 1999;20:1417-1421.
13. Watanabe M, Yamashita T, Hara A, et al. High signal intensity in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paresis. Neuroradiology 2001;43:231-233.
14. Levin MC, Lehky TJ, Fierlage AN, et al. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med 1997;336:839-844.
15. Kiwaki T, Umehara F, Arimura Y, et al. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 2003;206:17-21.